Pulse Biosciences (PLSE) Profit After Tax (2015 - 2026)

Pulse Biosciences' Profit After Tax history runs 11 years deep, the most recent figure standing at -$19.4 million for Q3 2025.

• In Q3 2025, Profit After Tax fell 52.88% year-over-year to -$19.4 million; the TTM figure through Sep 2025 stood at -$74.7 million (down 61.99% YoY), while the FY2025 annual figure was $72.8 million, up 235.86% from the prior year.
• Profit After Tax for Q3 2025 stood at -$19.4 million, down from -$19.2 million in the prior quarter.
• The five-year high for Profit After Tax was -$9.2 million in Q4 2022, with the low at -$19.4 million in Q4 2024.
• The 5-year median for Profit After Tax is -$14.3 million (2021), against an average of -$14.4 million.
• The sharpest annual moves came in 2023 and 2025: Profit After Tax soared 43.26% in 2023, then tumbled 68.39% in 2025.
• Pulse Biosciences' Profit After Tax stood at -$15.4 million in 2021, then jumped by 40.34% to -$9.2 million in 2022, then fell by 29.75% to -$11.9 million in 2023, then tumbled by 62.45% to -$19.4 million in 2024, then changed by 0.0% to -$19.4 million in 2025.
• Business Quant data shows PLSE's Profit After Tax at -$19.4 million in Q3 2025, -$19.2 million in Q2 2025, and -$16.8 million in Q1 2025.